• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受重组组织型纤溶酶原激活剂治疗患者的护理

Care of the patient receiving recombinant tissue plasminogen activator.

作者信息

White-Williams C

出版信息

J Cardiovasc Nurs. 1989 Nov;4(1):62-7.

PMID:2513380
Abstract

This article describes a case study of a 42-year-old man who received recombinant tissue plasminogen activator (rt-PA) therapy for treatment of an acute myocardial infarction. The case study describes the nursing management of this patient beginning with the initial assessment for candidacy for rt-PA through the hospital course and follow-up after discharge.

摘要

本文描述了一名42岁男性接受重组组织型纤溶酶原激活剂(rt-PA)治疗急性心肌梗死的病例研究。该病例研究描述了对该患者的护理管理,从最初评估rt-PA治疗的适用性开始,贯穿住院过程及出院后的随访。

相似文献

1
Care of the patient receiving recombinant tissue plasminogen activator.接受重组组织型纤溶酶原激活剂治疗患者的护理
J Cardiovasc Nurs. 1989 Nov;4(1):62-7.
2
Non neutralizing antibodies to tissue type plasminogen activator in the serum of acute myocardial infarction patients treated with the recombinant protein.接受重组蛋白治疗的急性心肌梗死患者血清中针对组织型纤溶酶原激活剂的非中和抗体
Thromb Haemost. 1996 Aug;76(2):234-8.
3
Addendum: a standardized nursing care plan for the acute myocardial infarction patient receiving tissue-type plasminogen activator.
Heart Lung. 1987 Nov;16(6 Pt 2):794-800.
4
[Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator].静脉注射重组组织型纤溶酶原激活剂与静脉注射链激酶治疗急性心肌梗死患者有效性的比较随机研究。欧洲重组组织型纤溶酶原激活剂合作研究组报告
Klin Wochenschr. 1988;66 Suppl 12:77-85.
5
[Anaphylactoid reaction during administration of tissue plasminogen activator (t-PA)].[组织型纤溶酶原激活剂(t-PA)给药期间的类过敏反应]
G Ital Cardiol. 1997 Mar;27(3):278-80.
6
Preventing coronary artery reocclusion following t-PA.
Crit Care Nurse. 1990 Nov-Dec;10(10):52-8.
7
What you should know about thrombolytic therapy for acute MI.关于急性心肌梗死溶栓治疗你应该了解的内容。
Am J Nurs. 1993 Sep;93(9):24-31; quiz 33.
8
Clopidogrel-rt-PA-heparin combination in the treatment of acute myocardial infarction.氯吡格雷-重组组织型纤溶酶原激活剂-肝素联合用药治疗急性心肌梗死
Semin Thromb Hemost. 1999;25 Suppl 2:69-75.
9
Recombinant tissue-type plasminogen activator in acute myocardial infarction: role of the critical care nurse.重组组织型纤溶酶原激活剂在急性心肌梗死中的应用:重症护理护士的作用
Heart Lung. 1987 Nov;16(6 Pt 2):779-86.
10
[Variations in hemostasis and fibrinolysis during the treatment of acute myocardial infarct (AMI) with tissue-type plasminogen activator (TTPA). A study of 17 cases].
Arch Inst Cardiol Mex. 1993 May-Jun;63(3):235-40.